Xin Lang Cai Jing·2025-11-20 03:23Core Viewpoint - Tiger Med's stock price has experienced a decline of 5.53% year-to-date, with a significant drop of 13.21% over the past five trading days, indicating potential concerns among investors regarding the company's performance and market position [1]. Financial Performance - For the period from January to September 2025, Tiger Med reported a revenue of 5.026 billion yuan, reflecting a year-on-year decrease of 0.82%. However, the net profit attributable to shareholders increased by 25.45% to 1.020 billion yuan [2]. - The company has distributed a total of 2.458 billion yuan in dividends since its A-share listing, with 1.154 billion yuan distributed over the past three years [3]. Stock Market Activity - As of November 20, Tiger Med's stock was trading at 51.32 yuan per share, with a market capitalization of 44.188 billion yuan. The stock has seen a trading volume of 264 million yuan and a turnover rate of 0.90% [1]. - The net outflow of main funds was 22.6355 million yuan, with large orders showing a buy of 466.036 million yuan and a sell of 688.923 million yuan, indicating a higher selling pressure [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders for Tiger Med was 48,400, a decrease of 6.01% from the previous period. The top circulating shareholder is Hong Kong Central Clearing Limited, holding 48.3625 million shares, an increase of 25.0969 million shares from the previous period [2][3].